You just read:

Innovate Biopharmaceuticals, Targeting Celiac Disease and Ulcerative Colitis, Meeting with Potential Investors, Partners During J.P. Morgan Healthcare Conference

News provided by

Innovate Biopharmaceuticals Inc.

04 Jan, 2017, 08:03 ET